Clinical Trials Browser

Unknown × Prostatic Neoplasms, Castration-Resistant × enzalutamide × Clear all

NCT02254785 2017-12-06

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms, Castration-Resistant